Search for: "AMGEN INC." Results 341 - 360 of 704
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
30 Jun 2014, 9:00 am
Omnicare agreed to pay the government $4.19 million to settle claims Omnicare solicited and received kickbacks from Amgen Inc., a drug manufacturer, for participating in “therapeutic interchange programs” aimed at switching Medicaid beneficiaries from another drug to one of Amgen’s products. [read post]
25 Jun 2014, 12:49 pm by Richard Booth
The question has really been before the court twice before, first in the earlier iteration of this case and then in Amgen Inc. v. [read post]
22 Apr 2014, 7:17 pm by Maureen Johnston
The petition of the day is: Amgen Inc. v. [read post]
11 Apr 2014, 9:42 pm by Patent Docs
Amgen Inc., and preparing now for the strict litigation timelines once the first applications are filed; • Integrating the monumental changes under the AIA including inter partes review and post-grant review into your biosimilars prosecution and litigation strategies; •... [read post]
19 Mar 2014, 9:00 am by Paula Bremner
There are two other pending biologic cases in Canada: (1) Teva’s filgrastim Subsequent Biologic Entry (“SEB”) case against Amgen was discontinued on consent in August 2013 (the parties had earlier settled in the US). [read post]
26 Feb 2014, 10:25 am by Barry Barnett
Justice Kennedy (and Justice Scalia) sat on the Court that handed down Basic, Inc. v. [read post]
27 Jan 2014, 11:40 am
Ed. 2d 179 (2007) (noting that courts ruling on 12(b)(6) motions to dismiss may take into consideration "matters of which a court may take judicial notice"); In re Amgen Inc. [read post]